Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5
Frequently Asked Questions
What is Market Cap of Can-Fite Biopharma Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Can-Fite Biopharma Ltd - ADR market cap is $10.41M.
What is the 52-week high for Can-Fite Biopharma Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Can-Fite Biopharma Ltd - ADR 52 week high is $3.12 as of September 10, 2025.
What is the 52-week low for Can-Fite Biopharma Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Can-Fite Biopharma Ltd - ADR 52 week low is $0.6301 as of September 10, 2025.
What is Can-Fite Biopharma Ltd - ADR stock price today?
Can-Fite Biopharma Ltd - ADR stock price today is $0.6606.
What was Can-Fite Biopharma Ltd - ADR stock price yesterday?
Can-Fite Biopharma Ltd - ADR stock price yesterday was $0.66.
What is the PE ratio of Can-Fite Biopharma Ltd - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Can-Fite Biopharma Ltd - ADR’s P/E ratio is -0.36.
What is the Price-to-Book ratio of Can-Fite Biopharma Ltd - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Can-Fite Biopharma Ltd - ADR P/B ratio is 2.0861.
What is the 50-day moving average of Can-Fite Biopharma Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Can-Fite Biopharma Ltd - ADR 50-day moving average is $0.8057.
How many employess does Can-Fite Biopharma Ltd - ADR has?